vs
AMERICAS CARMART INC（CRMT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
AMERICAS CARMART INC的季度营收约是REPLIGEN CORP的1.4倍（$286.3M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -7.8%，领先14.6%），REPLIGEN CORP同比增速更快（13.6% vs 0.2%），REPLIGEN CORP自由现金流更多（$17.6M vs $8.3M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.1%）
Americas CarMart Inc是美国专业汽车零售商，主要销售二手车，为信用记录有限或信用不佳的客户提供定制化内部融资方案，其线下门店网络集中在美国南部和中西部地区，服务购车市场中需求未被充分覆盖的消费群体。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CRMT vs RGEN — 直观对比
营收规模更大
CRMT
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出13.5%
0.2%
净利率更高
RGEN
高出14.6%
-7.8%
自由现金流更多
RGEN
多$9.3M
$8.3M
两年增速更快
RGEN
近两年复合增速
9.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $286.3M | $197.9M |
| 净利润 | $-22.5M | $13.3M |
| 毛利率 | 37.5% | 52.5% |
| 营业利润率 | -9.6% | 9.0% |
| 净利率 | -7.8% | 6.7% |
| 营收同比 | 0.2% | 13.6% |
| 净利润同比 | -540.7% | 143.9% |
| 每股收益（稀释后） | $-2.71 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRMTRGEN
| Q4 25 | $286.3M | $197.9M | ||
| Q3 25 | $276.2M | $188.8M | ||
| Q2 25 | $309.7M | $182.4M | ||
| Q1 25 | $263.5M | $169.2M | ||
| Q4 24 | $285.8M | $174.1M | ||
| Q3 24 | $287.2M | $154.9M | ||
| Q2 24 | $309.7M | $154.1M | ||
| Q1 24 | $240.4M | $151.3M |
净利润CRMTRGEN
| Q4 25 | $-22.5M | $13.3M | ||
| Q3 25 | $-5.7M | $14.9M | ||
| Q2 25 | $10.6M | $14.9M | ||
| Q1 25 | $3.2M | $5.8M | ||
| Q4 24 | $5.1M | $-30.3M | ||
| Q3 24 | $-964.0K | $-654.0K | ||
| Q2 24 | $426.0K | $3.3M | ||
| Q1 24 | $-8.5M | $2.1M |
毛利率CRMTRGEN
| Q4 25 | 37.5% | 52.5% | ||
| Q3 25 | 36.6% | 53.2% | ||
| Q2 25 | 36.4% | 50.0% | ||
| Q1 25 | 35.7% | 53.6% | ||
| Q4 24 | 39.4% | 26.1% | ||
| Q3 24 | 35.0% | 50.0% | ||
| Q2 24 | 35.1% | 49.8% | ||
| Q1 24 | 34.2% | 49.5% |
营业利润率CRMTRGEN
| Q4 25 | -9.6% | 9.0% | ||
| Q3 25 | -2.7% | 8.9% | ||
| Q2 25 | 4.0% | 7.6% | ||
| Q1 25 | 1.7% | 3.9% | ||
| Q4 24 | 2.5% | -17.7% | ||
| Q3 24 | -0.4% | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | -4.3% | 1.3% |
净利率CRMTRGEN
| Q4 25 | -7.8% | 6.7% | ||
| Q3 25 | -2.1% | 7.9% | ||
| Q2 25 | 3.4% | 8.2% | ||
| Q1 25 | 1.2% | 3.4% | ||
| Q4 24 | 1.8% | -17.4% | ||
| Q3 24 | -0.3% | -0.4% | ||
| Q2 24 | 0.1% | 2.2% | ||
| Q1 24 | -3.6% | 1.4% |
每股收益（稀释后）CRMTRGEN
| Q4 25 | $-2.71 | $0.24 | ||
| Q3 25 | $-0.69 | $0.26 | ||
| Q2 25 | $1.50 | $0.26 | ||
| Q1 25 | $0.37 | $0.10 | ||
| Q4 24 | $0.61 | $-0.55 | ||
| Q3 24 | $-0.15 | $-0.01 | ||
| Q2 24 | $0.09 | $0.06 | ||
| Q1 24 | $-1.34 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $122.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $555.0M | $2.1B |
| 总资产 | $1.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CRMTRGEN
| Q4 25 | $122.4M | $767.6M | ||
| Q3 25 | $9.7M | $748.7M | ||
| Q2 25 | $9.8M | $708.9M | ||
| Q1 25 | $8.5M | $697.2M | ||
| Q4 24 | $8.0M | $757.4M | ||
| Q3 24 | $4.7M | $784.0M | ||
| Q2 24 | $5.5M | $809.1M | ||
| Q1 24 | $4.2M | $780.6M |
总债务CRMTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CRMTRGEN
| Q4 25 | $555.0M | $2.1B | ||
| Q3 25 | $564.8M | $2.1B | ||
| Q2 25 | $569.4M | $2.1B | ||
| Q1 25 | $557.8M | $2.0B | ||
| Q4 24 | $553.6M | $2.0B | ||
| Q3 24 | $471.1M | $2.0B | ||
| Q2 24 | $470.6M | $2.0B | ||
| Q1 24 | $468.9M | $2.0B |
总资产CRMTRGEN
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.6B | $2.9B | ||
| Q2 25 | $1.6B | $2.9B | ||
| Q1 25 | $1.6B | $2.9B | ||
| Q4 24 | $1.6B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.5B | $2.9B | ||
| Q1 24 | $1.5B | $2.8B |
负债/权益比CRMTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $8.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 2.9% | 8.9% |
| 资本支出强度资本支出/营收 | 0.3% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-11.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CRMTRGEN
| Q4 25 | $9.1M | $25.7M | ||
| Q3 25 | $-5.9M | $48.1M | ||
| Q2 25 | $19.2M | $28.6M | ||
| Q1 25 | $-30.8M | $15.0M | ||
| Q4 24 | $-22.2M | $39.2M | ||
| Q3 24 | $-15.0M | $49.3M | ||
| Q2 24 | $-10.7M | $42.2M | ||
| Q1 24 | $13.0M | $44.7M |
自由现金流CRMTRGEN
| Q4 25 | $8.3M | $17.6M | ||
| Q3 25 | $-6.4M | $43.4M | ||
| Q2 25 | $18.4M | $21.5M | ||
| Q1 25 | $-31.5M | $11.4M | ||
| Q4 24 | $-23.6M | $33.6M | ||
| Q3 24 | $-16.0M | $42.3M | ||
| Q2 24 | $-12.0M | $37.4M | ||
| Q1 24 | $10.2M | $36.4M |
自由现金流率CRMTRGEN
| Q4 25 | 2.9% | 8.9% | ||
| Q3 25 | -2.3% | 23.0% | ||
| Q2 25 | 5.9% | 11.8% | ||
| Q1 25 | -12.0% | 6.8% | ||
| Q4 24 | -8.3% | 19.3% | ||
| Q3 24 | -5.6% | 27.3% | ||
| Q2 24 | -3.9% | 24.3% | ||
| Q1 24 | 4.3% | 24.0% |
资本支出强度CRMTRGEN
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.2% | 2.5% | ||
| Q2 25 | 0.3% | 3.9% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.3% | 4.5% | ||
| Q2 24 | 0.4% | 3.1% | ||
| Q1 24 | 1.1% | 5.5% |
现金转化率CRMTRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 1.81× | 1.92× | ||
| Q1 25 | -9.73× | 2.57× | ||
| Q4 24 | -4.36× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -25.18× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMT
| Sales Used Autos | $241.4M | 84% |
| Service Contract Sales | $23.6M | 8% |
| Wholesales Third Party | $12.6M | 4% |
| Payment Protection Plan Revenue | $8.7M | 3% |
RGEN
暂无分部数据
